Guidelines to assure the quality, safety and efficacy of live attenuated rotavirus vaccines (oral)

P. D. Minor*, M. L. Pombo, W. Wainwright, D. J. Wood, T. Q. Zhou, R. Dobbelaer, M. Powell, M. P. Kieny, D. Steele, A. Bentsi-Enchill, L. Chocarro

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

7 Citations (Scopus)

Abstract

This document provides guidance to national regulatory authorities and vaccine manufacturers on the production, quality control and evaluation of safety and efficacy of live attenuated rotavirus vaccines (oral) by outlining, in detail, international regulatory expectations for product characterization. It should be read in conjunction with the WHO guidelines on nonclinical evaluation of vaccines (1), and the WHO guidelines on clinical evaluation of vaccines: regulatory expectations (2), in order to understand the whole process of vaccine evaluation. Advice that is specific to the nonclinical or clinical evaluation of live attenuated rotavirus vaccines is provided to supplement these two generic documents. The following text is written in the form of guidelines instead of recommendations. Guidelines allow greater flexibility than recommendations with respect to expected future developments in the field.

Original languageEnglish
Title of host publicationWHO Expert Committee on Biological Standardization - Fifty-sixth Report
Pages133-188
Number of pages56
Edition941
Publication statusPublished - 2007
Externally publishedYes

Publication series

NameWorld Health Organization - Technical Report Series
Number941
ISSN (Print)0512-3054

Fingerprint

Dive into the research topics of 'Guidelines to assure the quality, safety and efficacy of live attenuated rotavirus vaccines (oral)'. Together they form a unique fingerprint.

Cite this